期刊
BRITISH JOURNAL OF CANCER
卷 96, 期 2, 页码 189-195出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6603515
关键词
angiogenesis inhibitors; biomarkers; clinical trials; dynamic contrast; enhanced magnetic resonance imaging; image analysis
类别
资金
- MRC [G0601746] Funding Source: UKRI
- Medical Research Council [G0601746] Funding Source: researchfish
- Medical Research Council [G0601746] Funding Source: Medline
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is now frequently used in early clinical trial assessment of antiangiogenic and vascular disrupting compounds. Evidence of drug efficacy and dose-dependent response has been demonstrated with some angiogenesis inhibitors. This review highlights the critical issues that influence T-1-weighted DCE-MRI data acquisition and analysis, identifies important areas for future development and reviews the clinical trial findings to date.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据